講演・口頭発表等 - 安齋　達彦

分割表示  38 件中 1 - 20 件目  ／  全件表示 >>

  1. Tatsuhiko Anzai, Kunihiko Takahashi. A multivariate model in longitudinal meta-analysis of omega-3 fatty acid supplementation for major depressive disorder. XXXII International Biometric Conference 2024.12.13

  2. Michio Yamamoto, Tatsuhiko Anzai, Kunihiko Takahashi. A spatial scan statistic based on partially linear functional additive models. 32nd International Biometrc Conference (IBC2024) 2024.12.10

  3. Li Yajie, Yuka Inamochi, Tatsuhiko Anzai, Noriyuki Wakabayashi, Kunihiko Takahashi, Kenji Fueki. An Explainable Artificial Intelligence for Designing Removable Partial Denture Framework. 口腔病学会第89回学術大会 2024.12.07 東京科学大学

  4. Li Yajie, Yuka Inamochi, Tatsuhiko Anzai, Kazuki Sakamoto, Eung-Yeol Kim, Hirokazu Sato, Taku Nemoto, Noriyuki Wakabayashi, Kunihiko Takahashi, Kenji Fueki. An Explainable Artificial Intelligence for Designing Removable Partial Denture Framework. The 14th Biennial Congress of the Asian Academy of Prosthodontics 2024.07.06 幕張メッセ

  5. Michio Yamamoto, Tatsuhiko Anzai, Kunihiko Takahashi. A functional generalized additive model-based scan statistic for disease cluster detection. 6th International Conference on Econometrics and Statistics (EcoSta 2023) 2023.08.01

  6. Ayumi Fujimoto, Tatsuhiko Anzai, Takahiro Fukuda, Naoyuki Uchida, Takanori Ohta, Takehiko Mori, Masashi Sawa, Satoshi Yoshioka, Toshihiro Miyamoto, Hitoji Uchiyama, Yuta Katayama, Ken-ichi Matsuoka, Souichi Shiratori, Hideyuki Nakazawa, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Eisei Kondo, Ritsuro Suzuki.. Impact of Event-Free Survival Status after Stem Cell Transplantation on Subsequent Survivalin Lymphoma Patients.. The 2021 Transplantation & Cellular Therapy Meetings 2021.02

  7. Tanaka Y, Kameda H, Saito K, Kaneko Y, Tanaka E, Yasuda S, Tamura N, Fujio K, Fujii T, Kojima T, Anzai T, Fujino Y, Matsuda S, Kohsaka H. FACTORS THAT AFFECT THE RESPONSE TO TOCILIZUMAB WITH REGARD TO WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A 2-YEAR FOLLOW-UP OF THE FIRST ACT-SC STUDY. Annals of the Rheumatic Diseases. 78, 1667. 2019

  8. Ichinose M, Minakata Y, Motegi T, Ueki J, Gon Y, Seki T, Anzai T, Nakamura S, Hirata K.. Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease (VESUTO Study): A Randomized Crossover Trial. American Journal of Respiratory and Critical Care Medicine. 197. 2018

  9. Minakata Y, Motegi T, Ueki J, Gon Y, Seki T, Anzai T, Nakamura S, Hirata K, Ichinose M.. Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study.. European Respiratory Journal. 52. 2018

  10. Tanaka Y, Kameda H, Saito K, Kaneko Y, Tanaka E, Yasuda S, Tamura N, Fujio K, Fujii T, Kojima T, Anzai T, Hamada C, Fujino Y, Matsuda S, Kohsaka H. Improvement in Overall Work Productivity Among Biologic-Naïve Patients With Rheumatoid Arthritis Treated With Tocilizumab Subcutaneous Injection: A Prospective, Real-World, Observational Study in Japan. Arthritis & Rheumatology. 69. 2017

  11. Ichinose M., Minakata Y., Motegi T., Ueki J., Seki T., Anzai T., Takizawa A., Gronke L., Hirata K. STUDY DESIGN OF VESUTO; STUDY TO EVALUATE THE EFFICACY OF TIOTROPIUM + OLODATEROL VS TIOTROPIUM ON LUNG HYPERINFLATION, EXERCISE CAPACITY, AND PHYSICAL ACTIVITY IN JAPANESE COPD PATIENTS. RESPIROLOGY. 21, 179. 2016

  12. Nomura K, Takahashi K, Hinomura Y, Kawaguchi G, Matsushita Y, Marui H, Anzai T, Hashiguchi M and Mochizuki M. An Assessment of How the Outputs from Signal Detection Can Be Effected by Variation of Database Profile by Analysing Adverse Events Reports of FDA and PMDA . Pharmacoepidemiology and Drug Safety. 22, 301. 2013

  13. Anzai T, Takahashi K, Tango T. An extension of the Gamma Poisson Shrinker method for signal detection based on spontaneous adverse drug reaction reports.. XXVIth International Biometric Conference. Kobe. 2012

  14. Anzai T, Shimadzu H, Endo T. Modelling duration of necessary and non-necessary activities in daily life: fitting mixture models to Japanese time use survey data. . Proceedings of the 23rd International Workshop on Statistical Modelling (Ed. P. Eilers), 93-98. 2008

  15. 梶原瑠太，安齋達彦，高橋邦彦. COVID-19流行期前後の副作用自発報告におけるシグナル検出指標の変化. 第35回日本疫学会学術総会 2025.02.14

  16. 安齋達彦, 高橋邦彦. オメガ３脂肪酸による抗うつ効果：投与期間・用量を考慮したメタアナリシス. 第35回日本疫学会学術総会 2025.02.13

  17. 安齋達彦, 横山徹爾, 高橋邦彦. 国民健康・栄養調査における都道府県別指標のベイズ推定. 第83回日本公衆衛生学会総会 2024.10.31

  18. 西田優紀, 安齋達彦, 高橋邦彦, 勝川史憲. メタボリックシンドロームの類型化に基づく医療費および死亡率との関連. 第83回日本公衆衛生学会総会 2024.10.30

  19. Kazuki Takahashi, Miho Kobayashi, Hisae Katsumata, Mizuki Tanaka, Yukinori Ikeda, Tatsuhiko Anzai, Katarzyna A. Podyma-Inoue, Jihwan Park, Kunihiko Takahashi, Yasuhiro Yoshimatsu, Yukiko T. Matsunaga, Tetsuro Watabe. がん微小環境においてCD40は部分的な内皮間葉移行を起こした内皮細胞集団において発現している. 第83回日本癌学会学術総会 2024.09.19 福岡市

  20. 稲用友佳，安齋達彦，高橋邦彦，笛木賢治. Convolutional Neural Networkを用いた 部分床義歯の設計を予測するAI開発. 第６回日本メディカルAI学会学術集会 2024.06.21 名古屋市公会堂

< 前のページ - 次のページ >

  • 1
  • 2
このページの先頭へ▲